Vontobel Holding Ltd. Acquires New Stake in Dolby Laboratories, Inc. (NYSE:DLB)

Vontobel Holding Ltd. acquired a new stake in Dolby Laboratories, Inc. (NYSE:DLB) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,842 shares of the electronics maker’s stock, valued at approximately $1,237,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Fifth Third Bancorp boosted its position in shares of Dolby Laboratories by 82.7% during the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 163 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in Dolby Laboratories by 436.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker’s stock valued at $29,000 after acquiring an additional 301 shares in the last quarter. Mather Group LLC. lifted its position in Dolby Laboratories by 36.8% in the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker’s stock valued at $41,000 after acquiring an additional 142 shares in the last quarter. First Horizon Advisors Inc. increased its stake in Dolby Laboratories by 22.7% in the 3rd quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock valued at $60,000 after buying an additional 146 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in Dolby Laboratories by 207.5% in the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker’s stock valued at $61,000 after buying an additional 525 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 12,338 shares of the business’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $78.08, for a total value of $963,351.04. Following the transaction, the executive vice president now owns 62,397 shares in the company, valued at approximately $4,871,957.76. The trade was a 16.51 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Ryan Nicholson sold 7,000 shares of the business’s stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total transaction of $588,490.00. Following the completion of the transaction, the chief accounting officer now owns 29,758 shares in the company, valued at $2,501,755.06. The trade was a 19.04 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 182,917 shares of company stock worth $14,861,429 in the last 90 days. 38.39% of the stock is owned by company insiders.

Dolby Laboratories Stock Performance

NYSE DLB opened at $83.72 on Tuesday. Dolby Laboratories, Inc. has a 52-week low of $66.35 and a 52-week high of $89.66. The company has a market capitalization of $7.99 billion, a P/E ratio of 30.78 and a beta of 0.98. The company has a fifty day moving average of $80.35 and a 200-day moving average of $76.10.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date is Tuesday, February 11th. Dolby Laboratories’s payout ratio is presently 48.53%.

Analyst Ratings Changes

Several brokerages have recently issued reports on DLB. StockNews.com lowered shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research note on Friday, January 31st. Barrington Research reissued an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, February 13th. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, January 30th.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.